1. Mankind Pharma
stock logo

64% Buy

Mankind Pharma Share Price

MANKIND

₹2,484.50+₹53.10 (2.18%) TodayLast updated on 13 Sep, 2024 | 13:19 IST
Please wait...
  • News

  • Company overview

  • Fundamentals

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹97,467 Crs

Open

₹2,448.40

Close

₹2,431.40

Circuit range

₹2,917.65 - ₹1,945.15

Day range

₹2,448.00 - ₹2,564.95

Year range

₹1,683.05 - ₹2,564.95

Volume

8,13,205

Avg. traded

₹2,500.38

Revenue (12m)

₹10,650 Crs

Mankind PharmaMankind Pharma Limited is an India-based pharmaceutical company. It is engaged in developing, manufacturing, and marketing a range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It offers healthcare solutions for a range of healthcare needs with a portfolio that includes anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/ central nervous system, vitamins, minerals and nutrients and respiratory therapies. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others. Its branded product portfolio spans women’s health, fertility and critical care, with several brands in their respective therapy areas. Its subsidiaries include Lifestar Pharma Private Limited, Magnet Labs Private Limited, Jaspack Industries Private Limited, and others.

Mankind Pharma Key indicators

arrow

52 week high

₹2,564.95

52 week low

₹1,683.05

P/E ratio

49.74

P/B ratio

9.86

ROE

20.98%

ROCE

26.13%

Dividend yield

--

Debt/Equity ratio

EPS

45.52

Learn more

Investment checklist: (3/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

64%

Hold

27%

Sell

9%

This analysis is based on the reviews of 11 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

26.94%

Net profit margin

18.95%

ROE

20.98%

ROA

17.54%

ROCE

26.13%

Learn more

Mankind Pharma Share Price history

arrow
DayOpenCloseDay’s change
Thu, Sep 12 2024
₹2,443.05
₹2,431.40
-0.06%
Wed, Sep 11 2024
₹2,448.00
₹2,432.75
-0.63%
Tue, Sep 10 2024
₹2,454.30
₹2,448.15
+1.50%
Mon, Sep 9 2024
₹2,466.00
₹2,411.95
-0.47%
Fri, Sep 6 2024
₹2,480.20
₹2,423.35
-2.01%
Thu, Sep 5 2024
₹2,415.00
₹2,473.15
+2.46%
Wed, Sep 4 2024
₹2,392.00
₹2,413.70
+0.95%
Tue, Sep 3 2024
₹2,412.85
₹2,391.10
-0.00%

Shareholding info

arrow

Promoters (74.87%)

Mutual Funds (7.37%)

Retail and other (3.61%)

Foreign institutions-FII (11.58%)

Other domestic institutions (2.58%)

Promoters

Learn more

More

Frequently asked questions